International Oncology Network - Cancer & Hematology News
November 2005 Blog Posts (1)
Breast Cancer in Young Women: Emotional Support Remains Crucial
A deadly disease. You may think you can’t get it. But it can happen to anybody. How to cope?
In September 2000, one week before turning 32, Hazel Flynt, a specialist in the study of patient-centred care, crashed into a wall she couldn’t have imagined was in front of her. The mother of a toddler daughter and an infant son was diagnosed with breast cancer. "I thought people had to be in their 50s to get cancer," the Amsterdam resident says. "And then it happened to me.” Flynt was… Continue
In September 2000, one week before turning 32, Hazel Flynt, a specialist in the study of patient-centred care, crashed into a wall she couldn’t have imagined was in front of her. The mother of a toddler daughter and an infant son was diagnosed with breast cancer. "I thought people had to be in their 50s to get cancer," the Amsterdam resident says. "And then it happened to me.” Flynt was… Continue
Added by Peter Hofland, PhD on November 28, 2005 at 8:00pm — No Comments
Featured Blog Posts
- Trial of T-Cells Genetically-Engineered to Express an Anti-CD19 Chimeric Antigen Receptor Show Promise as NewTtreatment Approach for B-cell Malignancies
- New Finding Pinpoints a Critical Gene Involved in Melanoma Growth and Provides a Framework for Discovering Ways to Tackle Cancer Drug Resistance
- Personalized Cancer Therapy Requires New Strategies for Cancer Drug Development
- New Discovery Halts Breast Cancer Stem Cells – Suggesting A New Drug Therapy Target
- New Therapy Provide Significant Survival Benefit In Second-line Metastatic Hormone-refractory Prostate Cancer (mHRPC)
- Cancer Tutorial: Introduction to Drug Resistance
- Scientists Unveil Genetic Code for Skin and Lung Cancer
Latest Blog Posts
- Erlotinib is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
- Angelina Jolie: A Difficult Choice and A Courageous Decision
- Enzastaurin Does Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma Study
- Study Evaluates Treatment of High Dose Aldesleukin + Vemurafenib in Patients with Metastatic Melanoma
- New Diagnostic Test Effectively Predicts Rapid Metastatic Prostate Cancer (RMD) - Outperforms Existing Tools
- UK Charity Calls for More Attention and Awareness for Bladder Cancer
- Cryoablation Shows Promising Results in the Treatment of Breast Cancer
Most Popular Blog Posts
- PD-L1 Antibody MPDL3280A is well Tolerated in Phase I Study - No Limiting Toxicities Across a Range of Cancer Types
- Newly Identified microRNAs Could be Biomarkers for Early Diagnosis of Progression of Barrett's Esophagus and Esophageal Adenocarcinoma
- Scientific Advisory Board of Patient Advocate Organizations Disagree with Changes to Mammography Guidelines
- First Ever Estimate Reveals the Direct and Indirect Economic Burden of Cancer in Europe
- Sanofi's Selective JAK2 inhibitor (SAR302503) Meets Primary Endpoint in Phase II Trial
- Expense and Unaffordable Leukemia Treatment May Harm Patients
- UK NICE Upholds Its Decision Not to Approve Cabazitaxel for Use on the NHS
Blog Topics by Tags
Monthly Archives
2013
2012
- December (32)
- November (19)
- October (17)
- September (9)
- August (10)
- July (4)
- June (29)
- May (16)
- April (6)
- March (4)
- February (21)
- January (38)
2011
- December (47)
- November (32)
- October (21)
- September (32)
- August (18)
- July (23)
- June (83)
- May (45)
- April (54)
- March (36)
- February (62)
- January (43)
2010
- December (58)
- November (49)
- October (65)
- September (23)
- August (7)
- July (4)
- June (34)
- May (7)
- April (7)
- March (5)
- February (3)
- January (6)
2009
2008
- December (19)
2007
- April (1)
2005
2004
- September (1)
2001
- November (1)
ADVERTISEMENT
Bookmark / Share
Join the Conversation!
© 2013 Created by Peter Hofland, PhD.
